Key result
Elastin degradation serves as an effective biomarker in patients with chronic obstructive pulmonary disease.
Key points are not available for this paper at this time.
May inform COPD biomarker research; leaves open clinical adoption pending prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Turino et al. (2012) studied this question. Elastin degradation serves as an effective biomarker in patients with chronic obstructive pulmonary disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: